Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience

Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience

Abstract Background Convalescent plasma (CP) and hyperimmune plasma (HP) are passive immunotherapies consisting in the infusion of plasma from recovered people into infected patients. Following pre-existing evidence in many other viral diseases, such as SARS, MERS and Ebola, CP and HP have also been...

Full description

Bibliographic Details
Main Authors: Maria Grazia Cusi, Edoardo Conticini, Claudia Gandolfo, Gabriele Anichini, Gianni Gori Savellini, Serafina Valente, Federico Franchi, Sabino Scolletta, Elena Percivalle, Bruno Frediani
Format: Article
Language:English
Published: BMC 2021-07-01
Series:BMC Infectious Diseases
Subjects:
Convalescent plasma
Hyperimmune plasma
SARS-CoV2
COVID-19
Immunodeficiency
Online Access:https://doi.org/10.1186/s12879-021-06321-2

Similar Items

Similar Items